Log in
NASDAQ:MYL

Mylan Stock Forecast, Price & News

$15.86
0.00 (0.00 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$15.34
Now: $15.86
$16.15
50-Day Range
$14.30
MA: $15.43
$15.86
52-Week Range
$12.75
Now: $15.86
$23.11
Volume14.10 million shs
Average Volume6.49 million shs
Market Capitalization$8.59 billion
P/E Ratio29.92
Dividend YieldN/A
Beta1.45
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS. The company also provides prescription products, such as EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases. In addition, it markets OTC products, including Cold-EEZE, MidNite, Vivarin, Brufen, CB12, and EndWarts. The company offers its products to therapeutic areas, such as cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's health. Its customers include retail pharmacies, wholesalers and distributors, payers, and insurers and governments, as well as institutions, such as hospitals. Mylan N.V. has collaboration and license agreements with Pfizer Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; Fujifilm Kyowa Kirin Biologics Co. Ltd; and Revance Therapeutics, Inc. The company was founded in 1961 and is based in Hatfield, the United Kingdom.
Mylan logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.77 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:MYL
CUSIP62853010
Phone724-514-1800
Employees35,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.50 billion
Cash Flow$8.76 per share
Book Value$23.02 per share

Profitability

Net Income$16.80 million

Miscellaneous

Market Cap$8.59 billion
Next Earnings Date2/25/2021 (Estimated)
OptionableOptionable
$15.86
0.00 (0.00 %)
(As of 12/3/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MYL News and Ratings via Email

Sign-up to receive the latest news and ratings for MYL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Mylan (NASDAQ:MYL) Frequently Asked Questions

How has Mylan's stock price been impacted by COVID-19?

Mylan's stock was trading at $14.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MYL stock has increased by 9.6% and is now trading at $15.8550.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Mylan?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Mylan
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Mylan?

Wall Street analysts have given Mylan a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Mylan wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Mylan's next earnings date?

Mylan is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Mylan
.

How were Mylan's earnings last quarter?

Mylan (NASDAQ:MYL) released its quarterly earnings results on Friday, November, 6th. The company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.15. The firm had revenue of $2.97 billion for the quarter, compared to analysts' expectations of $3 billion. Mylan had a return on equity of 20.43% and a net margin of 2.35%. The firm's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.17 EPS.
View Mylan's earnings history
.

What price target have analysts set for MYL?

8 analysts have issued 12 month price objectives for Mylan's shares. Their forecasts range from $16.00 to $27.00. On average, they anticipate Mylan's stock price to reach $20.33 in the next twelve months. This suggests a possible upside of 28.2% from the stock's current price.
View analysts' price targets for Mylan
.

Who are some of Mylan's key competitors?

What other stocks do shareholders of Mylan own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (GILD), Alibaba Group (BABA), Pfizer (PFE), Teva Pharmaceutical Industries (TEVA), Micron Technology (MU), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Starbucks (SBUX) and General Electric (GE).

Who are Mylan's key executives?

Mylan's management team includes the following people:
  • Mr. Robert J. Coury, Exec. Chairman (Age 59, Pay $1.83M)
  • Ms. Heather Bresch, CEO & Exec. Director (Age 51, Pay $5.64M)
  • Mr. Rajiv Malik, Pres & Exec. Director (Age 59, Pay $4.47M)
  • Mr. Anthony Mauro, Chief Commercial Officer (Age 47, Pay $2.55M)
  • Mr. Paul B. Campbell, Chief Accounting Officer, Sr. VP & Corp. Controller
  • Ms. Melissa Trombetta, Head of Global Investor Relations
  • Mr. Dennis Zeleny, Chief Human Relations Officer (Age 65)
  • Ms. Deborah Autor, Sr. VP, Head of Strategic Global Quality & Regulatory Policy
  • Mr. Bill Szablewski, Head of Capital Markets
  • Mr. Joseph F. Haggerty, Corp. Sec.

What is Mylan's stock symbol?

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Who are Mylan's major shareholders?

Mylan's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.36%), State Street Corp (4.65%), Pzena Investment Management LLC (3.32%), Camber Capital Management LP (2.22%), AQR Capital Management LLC (1.41%) and Samlyn Capital LLC (1.31%). Company insiders that own Mylan stock include Goulds Bruce, Melina E Higgins, Paul Campbell, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt.
View institutional ownership trends for Mylan
.

Which institutional investors are selling Mylan stock?

MYL stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Harel Insurance Investments & Financial Services Ltd., Morgan Stanley, BlackRock Inc., Acadian Asset Management LLC, JPMorgan Chase & Co., AXA S.A., and Cubist Systematic Strategies LLC.
View insider buying and selling activity for Mylan
.

Which institutional investors are buying Mylan stock?

MYL stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Arrowstreet Capital Limited Partnership, Samlyn Capital LLC, Iridian Asset Management LLC CT, Camber Capital Management LP, MFN Partners Management LP, Massachusetts Financial Services Co. MA, and First Trust Advisors LP. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury, and Sjoerd S Vollebregt.
View insider buying and selling activity for Mylan
.

How do I buy shares of Mylan?

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Mylan's stock price today?

One share of MYL stock can currently be purchased for approximately $15.86.

How big of a company is Mylan?

Mylan has a market capitalization of $8.59 billion and generates $11.50 billion in revenue each year. The company earns $16.80 million in net income (profit) each year or $4.42 on an earnings per share basis. Mylan employs 35,000 workers across the globe.

What is Mylan's official website?

The official website for Mylan is www.mylan.com.

How can I contact Mylan?

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]

This page was last updated on 12/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.